In an environmental chemist in Gurugram, “Wegovy ya Ozempic hey what??” [Do you have Wegovy or Ozempic?] has become a daily refrain. Since semaglutide lost patent protection in India on March 20, and dozens of low-cost generics flooded the market, retail pharmacies have increasingly become the first point of contact for weight loss hopefuls, often … Read more
India is expected to see a GLP-1 boom as Novo Nordisk’s semaglutide patent expires in the country this month. GLP-1s such as Wegovy and Ozempic have made a big impact in the treatment of diabetes and weight loss, especially in the US. The expiring patent marks an important moment for India’s pharmaceutical and nutritional sectors, … Read more
Space travel isn’t as easy as it seems, though. The human body is not designed to function properly outside of the Earth’s gravitational pull. Muscles atrophy, bones become less dense, and walking becomes exercise. Space travel is not easy, especially when planning to travel to Mars. One thing that scientists are struggling to achieve is … Read more
Clearmind Medicine (Nasdaq: CMND) Filed a patent application in India on March 27, 2026 for the next generation, non-hallucinogenic neuroplastogen-derived compounds targeting mental health disorders and addiction. The filing, with the Indian Patent Office, expands the company’s global intellectual property portfolio and forms an exclusive worldwide license agreement with Yissumseeking … Read more